Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis - 22/02/24
Abstract |
Background |
Early recurrence (ER, recurrence within 2 years) is common in hepatocellular carcinoma (HCC) patients after ablation and resection. We aimed to compare ER and assess the associated risk factors.
Methods |
We collected data from patients underwent resection (1,235) or ablation (517) for early HCC (solitary tumor ≤5 cm). Baseline of patients were matched using propensity score matching.
Results |
In the matched cohort of 690 patients, the ablation group had a higher ER rate (37.4% vs. 19.4%; P < .001) than the resection group. Patients with ER had worse overall survival (OS) than those without ER in both the ablation (5-year OS: 60.4% vs. 86.7%) and resection groups (5-year OS: 59.2% vs. 88.1%). Ablation treatment was identified as an independent adverse prognostic factor for ER (hazard ratio: 2.751, P < .001). Resection conferred a significant favorable OS than ablation (2-year: 95.4% vs. 90.9%; 5-years: 83.8% vs. 77.0%).
Conclusions |
Resection was superior to ablation in minimizing the risk of ER and offering a better OS for patients with early HCC.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Early recurrence after local treatment is common in patients with hepatocellular carcinoma. |
• | Ablation is associated with risk of early recurrence. |
• | Resection is superior to ablation in reducing the risk of early recurrence. |
Keywords : Recurrence, Liver cancer, Prognosis, Treatment
Plan
Vol 228
P. 94-101 - février 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?